Plasma levels of soluble platelet glycoprotein V in acute coronary syndromes: A tool to monitor platelet activation by thrombin in arterial thrombosis

被引：0
|
作者：
Aleil, B
Mossard, JM
Wiesel, ML
Wolff, V
Attali, P
Gachet, C
Lanza, F
Cazenave, JP
机构：
[1] Etablissement Francais Sang, INSERM U311, Strasbourg, France
[2] Hop Civil, Serv Cardiol, Strasbourg, France
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3938
引用
收藏
页码：115B / 115B
页数：1
相关论文
共 50 条
  • [21] Gender differences in platelet activation in patients with acute coronary syndromes
    Charles, Mitch
    Wehner, Paulette
    Ferraris, Suellen
    Ferraris, Vic
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E52 - E52
  • [22] Role of oral blockade of platelet glycoprotein IIb/IIIa on neutrophil activation in patients with acute coronary syndromes
    Serrano, CV
    Nicolau, JC
    Venturinelli, M
    Baracioli, LM
    Anders, RJ
    Cannon, CP
    Ramires, JAF
    CARDIOVASCULAR DRUGS AND THERAPY, 2003, 17 (02) : 129 - 132
  • [23] Role of Oral Blockade of Platelet Glycoprotein IIb/IIIa on Neutrophil Activation in Patients with Acute Coronary Syndromes
    Carlos V. Serrano
    José C. Nicolau
    Margareth Venturinelli
    Luciano M. Baracioli
    Robert J. Anders
    Christopher P. Cannon
    José A. F. Ramires
    Cardiovascular Drugs and Therapy, 2003, 17 : 129 - 132
  • [24] The platelet in acute coronary syndromes: Defining the pivotal role of platelet glycoprotein IIb/IIIa receptor blockade
    Jesse, RL
    JOURNAL OF EMERGENCY MEDICINE, 1999, 17 (03): : 575 - 580
  • [25] Noncanonical Effects of Oral Thrombin and Factor Xa Inhibitors in Platelet Activation and Arterial Thrombosis
    Polzin, Amin
    Dannenberg, Lisa
    Thienel, Manuela
    Orban, Martin
    Wolff, Georg
    Hohlfeld, Thomas
    Zeus, Tobias
    Kelm, Malte
    Petzold, Tobias
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (02) : 122 - 130
  • [26] Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes
    Lekakis, John
    Bisti, Sofia
    Tsougos, Elias
    Papathanassiou, Athanasios
    Dagres, Nikolaos
    Ikonomidis, Ignatios
    Soteriadou, Ekaterini
    Tselepis, Alexandros D.
    Goudevenos, John
    Kremastinos, Dimitris Th.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 127 (01) : 46 - 50
  • [27] Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
    Topol, E
    Califf, R
    Simoons, M
    Diaz, R
    Paolasso, E
    Klein, W
    Boland, J
    DeBacker, G
    Armstrong, P
    Corbalan, R
    Isaza, D
    Widimsky, P
    Urrutia, C
    Luomanmäki, K
    Vahanian, A
    Karsch, K
    Cokkinos, D
    Karatasakis, G
    Toutouzas, P
    Rodas, M
    Keltai, M
    Chierchia, S
    Silva, E
    Erikssen, J
    Ruzyllo, W
    Stepinska, J
    Ribeiro, VD
    Fernandez-Ortiz, A
    Macaya, C
    Goy, J
    Deckers, J
    Skene, A
    Wilcox, R
    Guerci, A
    Harrington, R
    Hochman, J
    Holmes, D
    Kleiman, N
    Kopecky, S
    Lee, K
    Lincoff, A
    Ohman, E
    Pepine, C
    Isea, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (07): : 436 - 443
  • [28] Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
    Bhatt, DL
    Topol, EJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (12): : 1549 - 1558
  • [29] Emerging Treatment of Acute Coronary Syndromes with Platelet Glycoprotein IIB/IIIA Inhibitors
    Matthew T. Roe
    David J. Moliterno
    Journal of Thrombosis and Thrombolysis, 1999, 7 : 247 - 257
  • [30] Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB IIIA inhibitors
    Roe, MT
    Moliterno, DJ
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 7 (03) : 247 - 257
12345